CISPLATIN CARBOPLATIN CROSS-RESISTANCE IN OVARIAN-CANCER

被引：112

作者：

GORE, ME ^{[1
]}

FRYATT, I ^{[1
]}

WILTSHAW, E ^{[1
]}

DAWSON, T ^{[1
]}

ROBINSON, BA ^{[1
]}

CALVERT, AH ^{[1
]}

机构：

[1] ROYAL MARSDEN HOSP,GYNAECOL UNIT,FULHAM RD,LONDON SW3 6JJ,ENGLAND

来源：

BRITISH JOURNAL OF CANCER | 1989年 / 60卷 / 05期

关键词：

D O I：

10.1038/bjc.1989.356

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：767 / 769

页数：3

共 19 条

[1] USE OF HIGH-DOSE CIS-DICHLORODIAMMINE PLATINUM-(II) (NSC-119875) FOLLOWING FAILURE ON PREVIOUS CHEMOTHERAPY FOR ADVANCED-CARCINOMA OF THE OVARY [J].

BARKER, GH ;

WILTSHAW, E .

BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1981, 88 (12) :1192-1199

[2]

BOVEN E, 1985, CANCER RES, V45, P86

[3]

BRADNER WT, 1980, CISPLATIN CURRENT ST, P171

[4]

BRUCKNER HW, 1978, CANCER TREAT REP, V62, P555

[5]

BURCHENAL JH, 1979, CANCER TREAT REP, V63, P1493

[6] EARLY CLINICAL-STUDIES WITH CIS-DIAMMINE-1,1-CYCLOBUTANE DICARBOXYLATE PLATINUM-II [J].

CALVERT, AH ;

HARLAND, SJ ;

NEWELL, DR ;

SIDDIK, ZH ;

JONES, AC ;

MCELWAIN, TJ ;

RAJU, S ;

WILTSHAW, E ;

SMITH, IE ;

BAKER, JM ;

PECKHAM, MJ ;

HARRAP, KR .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1982, 9 (03) :140-147

[7]

CALVERT AH, 1989, IN PRESS J CLIN ONCO

[8]

EVANS BD, 1983, CANCER TREAT REP, V67, P997

[9]

KELSEN DP, 1983, LATINUM COORDINATION, P310

[10]

KNOX RJ, 1986, CANCER RES, V46, P1972

← 1 2 →